Mono- Versus Polyubiquitination: Differential Control of p53 Fate by Mdm2

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Science

• Publication date

  2003-12-12

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1126/SCIENCE.1091362PMID 14671306
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Disrupting TP53 in mouse models of human cancers

  2003cited by this paper
• Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation.

  2003cited by this paper
• Parc: a cytoplasmic anchor for p53.

  2003cited by this paper
• Polyubiquitination of p53 by a Ubiquitin Ligase Activity of p300

  2003cited by this paper
• Hypophosphorylation of Mdm2 Augments p53 Stability

  2002cited by this paper
• Nuclear degradation of p53 occurs during down‐regulation of the p53 response after DNA damage

  2002cited by this paper
• Acetylation of p53 Inhibits Its Ubiquitination by Mdm2*

  2002cited by this paper
• Cyclin G recruits PP2A to dephosphorylate Mdm2.

  2002cited by this paper
• Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization

  2002cited by this paper
• C-Terminal Ubiquitination of p53 Contributes to Nuclear Export

  2001cited by this paper
• Cocompartmentalization of p53 and Mdm2 is a major determinant for Mdm2-mediated degradation of p53.

  2001cited by this paper
• Human mdm2 Mediates Multiple Mono-ubiquitination of p53 by a Mechanism Requiring Enzyme Isomerization*

  2001cited by this paper
• Mechanisms underlying ubiquitination.

  2001cited by this paper
• Identification of p53 Sequence Elements That Are Required for MDM2-Mediated Nuclear Export

  2001cited by this paper
• An intact HDM2 RING-finger domain is required for nuclear exclusion of p53

  2000cited by this paper
• Multiple C-Terminal Lysine Residues Target p53 for Ubiquitin-Proteasome-Mediated Degradation

  2000cited by this paper
• MDM2-dependent ubiquitination of nuclear and cytoplasmic P53

  2000cited by this paper
• Generation of oscillations by the p53-Mdm2 feedback loop: a theoretical and experimental study.

  2000cited by this paper
• Multiple Lysine Mutations in the C-Terminal Domain of p53 Interfere with MDM2-Dependent Protein Degradation and Ubiquitination

  2000cited by this paper
• The MDM2 RING-finger domain is required to promote p53 nuclear export

  2000cited by this paper
• An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo

  2000cited by this paper
• Mdm2 Is a RING Finger-dependent Ubiquitin Protein Ligase for Itself and p53*

  2000cited by this paper
• Surfing the p53 network

  2000cited by this paper
• A leucine‐rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking

  1999cited by this paper
• Mdm2 association with p53 targets its ubiquitination

  1998cited by this paper
• A function for monoubiquitination in the internalization of a G protein-coupled receptor.

  1998cited by this paper
• Nuclear Export Is Required for Degradation of Endogenous p53 by MDM2 and Human Papillomavirus E6

  1998cited by this paper
• Mdm2 promotes the rapid degradation of p53

  1997cited by this paper
• Regulation of p53 stability by Mdm2

  1997cited by this paper
• Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53

  1997cited by this paper

• The Regulation of p53 by Ubiquitination and Implications for Therapeutic Targeting in Colorectal Cancer

  2026cites this paper
• The Structure, Pathogenesis, and Inhibition of the p53-MDM2 Pathway.

  2026cites this paper
• Proteasomal control of transcription factors: mechanisms, regulation and dysregulation.

  2026cites this paper
• Circ_0057105 promotes intrahepatic cholangiocarcinoma progression by sponging miR-1290 and regulating the MDM2/P53 pathway.

  2026cites this paper
• The multifunctional proline-rich domain of p53 tumor suppressor.

  2025cites this paper
• MDM2/p53-based live-cell quantitative FRET imaging for apoptosis drug discovery.

  2025cites this paper
• Insulin receptor tyrosine kinase substrate in health and disease (Review)

  2025cites this paper
• Trifluridine/tipiracil induces ferroptosis by targeting p53 via the p53-SLC7A11 axis in colorectal cancer 3D organoids

  2025cites this paper
• O-GlcNAcylation of DDB1 at Ser-764 by OGT promotes cancer cell stemness in colorectal cancer through increased polyubiquitination of p53

  2025cites this paper
• Structure and function of MDM2 and MDM4 in health and disease

  2025cites this paper
• A Perspective on Therapeutic Targeting Against Ubiquitin Ligases to Stabilize Tumor Suppressor Proteins

  2025cites this paper
• Therapy-Induced Senescence (TIS) and SASP: The p53-Mediated Interplay in Cancer Progression and Treatment

  2025cites this paper
• Mechanistic Role of the Mdm2/MdmX Lid Domain in Regulating Their Interactions with p53

  2025cites this paper
• Proteasome dynamics in response to metabolic changes

  2025cites this paper
• E3 Ubiquitin Ligases: Structures, Biological Functions, Diseases, and Therapy

  2025cites this paper
• Robust p53 phenotypes and prospective downstream targets in telomerase-immortalized human cells

  2025cites this paper
• The evolution of Nutlins as p53-MDM2 inhibitors

  2025cites this paper
• TSPYL5-driven G3BP1 nuclear membrane translocation facilitates p53 cytoplasm sequestration via accelerating RanBP2-mediated p53 sumoylation and nuclear export in neuroblastoma

  2025cites this paper
• The Arabidopsis E3 ubiquitin ligase DOA10A promotes localization of abscisic acid (ABA) receptors to the membrane through mono-ubiquitination in ABA signaling.

  2024cites this paper
• Cell fate regulation governed by p53: Friends or reversible foes in cancer therapy

  2024cites this paper
• Pancreatic β‑cell apoptosis in type 2 diabetes is related to post‑translational modifications of p53 (Review).

  2024cites this paper
• Decoding the Ubiquitin Language: Orchestrating Transcription Initiation and Gene Expression Through Chromatin Remodelers and Histones.

  2024cites this paper
• Nanoreceptors promote mutant p53 protein degradation by mimicking selective autophagy receptors

  2024cites this paper
• Pin1-Catalyzed Conformation Changes Regulate Protein Ubiquitination and Degradation

  2024cites this paper
• Hdm2 disrupts HdmX-mediated nuclear export of p53 by sequestering it in nucleus.

  2024cites this paper
• Friend or foe? Reciprocal regulation between E3 ubiquitin ligases and deubiquitinases.

  2024cites this paper
• Androgen receptor post-translational modifications and their implications for pathology.

  2024cites this paper
• ESF1 positively regulates MDM2 and promotes tumorigenesis.

  2024cites this paper
• Ubiquitin recruiting chimera: more than just a PROTAC

  2024cites this paper
• Unraveling the mechanisms of glioblastoma’s resistance: investigating the influence of tumor suppressor p53 and non-coding RNAs

  2024cites this paper
• A non-canonical role for a small nucleolar RNA in ribosome biogenesis and senescence.

  2024cites this paper
• Unraveling the Guardian: p53’s Multifaceted Role in the DNA Damage Response and Tumor Treatment Strategies

  2024cites this paper
• Arylamines QSAR-Based Design and Molecular Dynamics of New Phenylthiophene and Benzimidazole Derivatives with Affinity for the C111, Y268, and H73 Sites of SARS-CoV-2 PLpro Enzyme

  2024cites this paper
• Role of the ubiquitin–proteasome system on macrophages in the tumor microenvironment

  2024cites this paper
• USP47 deubiquitylates Groucho/TLE to promote Wnt–β-catenin signaling

  2023cites this paper
• Roles of p53-Mediated Host–Virus Interaction in Coronavirus Infection

  2023cites this paper
• Interplay between autophagy and proteasome during protein turnover.

  2023cites this paper
• The SWIB/MDM2 motif of UBE4B activates the p53 pathway

  2023cites this paper
• The roles of E3 ubiquitin ligases in cancer progression and targeted therapy

  2023cites this paper
• USP7 reduces the level of nuclear DICER, impairing DNA damage response and promoting cancer progression

  2023cites this paper
• Cytoplasmic localization of Mdm2 in cells expressing mutated NPM is mediated by p53

  2023cites this paper
• UBE1C is upregulated and promotes neddylation of p53 in lung cancer

  2023cites this paper
• Inhibition of USP7 induces p53-independent tumor growth suppression in triple-negative breast cancers by destabilizing FOXM1

  2023cites this paper
• A Narrative Review of the TP53 and Its Product the p53 Protein

  2023cites this paper
• Nuclear transport surveillance of p53 by nuclear pores in glioblastoma.

  2023cites this paper
• USP39-Mediated Non-Proteolytic Control of ETS2 Suppresses Nuclear Localization and Activity

  2023cites this paper
• The SUMOylation and ubiquitination crosstalk in cancer

  2023cites this paper
• Nanoassemblies from the aqueous extract of roasted coffee beans modulate the behavioral and molecular effects of smoking withdrawal–induced anxiety in female rats

  2023cites this paper
• EOAI, a ubiquitin-specific peptidase 5 inhibitor, prevents non-small cell lung cancer progression by inducing DNA damage

  2023cites this paper
• HERC3 regulates epithelial-mesenchymal transition by directly ubiquitination degradation EIF5A2 and inhibits metastasis of colorectal cancer

  2022cites this paper
• p53 regulation by ubiquitin and ubiquitin-like modifications

  2022cites this paper
• Targeting Post-Translational Regulation of p53 in Colorectal Cancer by Exploiting Vulnerabilities in the p53-MDM2 Axis

  2022cites this paper
• The roles of mouse double minute 2 (MDM2) oncoprotein in ocular diseases: A review.

  2022cites this paper
• Improved cognitive impairments by silencing DMP1 via enhancing the proliferation of neural progenitor cell in Alzheimer‐like mice

  2022cites this paper
• MDM2 inhibitors-mediated disruption of mitochondrial metabolism: A novel therapeutic strategy for retinoblastoma

  2022cites this paper
• The role of ubiquitination in spinal and bulbar muscular atrophy

  2022cites this paper
• Impact of TP53 mutations in Triple Negative Breast Cancer

  2022cites this paper
• Inorganic arsenic induces MDM2, p53, and their phosphorylation and affects the MDM2/p53 complex in vitro

  2022cites this paper
• Protein of a thousand faces: The tumor-suppressive and oncogenic responses of p53

  2022cites this paper
• Coiled-coil domain containing 3 suppresses breast cancer growth by protecting p53 from proteasome-mediated degradation

  2022cites this paper
• The Four Homeostasis Knights: In Balance upon Post-Translational Modifications

  2022cites this paper
• Cyclin-dependent kinase 5 regulates PSD-95 ubiquitination in Cyclin-dependent kinase 5 regulates PSD-95 ubiquitination in neurons neurons us how this document benefits you.

  2022cites this paper
• SIRT1 activation synergizes with FXR agonism in hepatoprotection via governing nucleocytoplasmic shuttling and degradation of FXR

  2022cites this paper
• HERC3 regulates epithelial-mesenchymal transition by directly ubiquitination degradation EIF5A2 and inhibits metastasis of colorectal cancer

  2022cites this paper
• Post-Translational Modifications of p53 in Ferroptosis: Novel Pharmacological Targets for Cancer Therapy

  2022cites this paper
• Progress in Anticancer Drug Development Targeting Ubiquitination-Related Factors

  2022cites this paper
• Cancer Stemness: p53 at the Wheel

  2021cites this paper
• Comparative Genomics Reveals Factors Associated with Phenotypic Expression of Wolbachia

  2021cites this paper
• Fungal Secondary Metabolites as Inhibitors of the Ubiquitin–Proteasome System

  2021cites this paper
• Targeted β‐catenin ubiquitination and degradation by multifunctional stapled peptides

  2021cites this paper
• Identification and characterization of Bombyx mori homologs of Bonus, Mdm2, Rad6, Sce, and Synoviolin

  2021cites this paper
• Ubiquitination on Lysine 247 of Newcastle Disease Virus Matrix Protein Enhances Viral Replication and Virulence by Driving Nuclear-Cytoplasmic Trafficking

  2021cites this paper
• Prenatal Diagnosis and the Spectrum of Involvement from Fragile X Mutations

  2021cites this paper
• Fast friends – Ubiquitin-like modifiers as engineered fusion partners

  2021cites this paper
• Inactivation of the tumor suppressor p53 by long noncoding RNA RMRP

  2021cites this paper
• UHRF2 commissions the completion of DNA demethylation through allosteric activation by 5hmC and K33-linked ubiquitination of XRCC1.

  2021cites this paper
• Deciphering the PTM codes of the tumor suppressor p53

  2021cites this paper
• Complementary omics strategies to dissect p53 signaling networks under nutrient stress

  2021cites this paper
• lncRNA TRMP-S directs dual mechanisms to regulate p27-mediated cellular senescence

  2021cites this paper
• The ion channel TRPM7 regulates zinc-depletion-induced MDMX degradation

  2021cites this paper
• An E3 ligase guide to the galaxy of small-molecule-induced protein degradation.

  2021cites this paper
• P53 TAD2 Domain (38-61) Forms Amyloid-like Aggregates in Isolation

  2021cites this paper
• The roles and regulation of MDM2 and MDMX: it is not just about p53

  2021cites this paper
• Mechanisms of TP53 Pathway Inactivation in Embryonic and Somatic Cells—Relevance for Understanding (Germ Cell) Tumorigenesis

  2021cites this paper
• PRDX2 promotes the proliferation of colorectal cancer cells by increasing the ubiquitinated degradation of p53

  2021cites this paper
• Chalcones as Promising Antitumor Agents by Targeting the p53 Pathway: An Overview and New Insights in Drug-Likeness

  2021cites this paper
• The Circadian Protein PER1 Modulates the Cellular Response to Anticancer Treatments

  2021cites this paper
• Regulation of p53 by E3s

  2021cites this paper
• The Ubiquitinated Axon: Local Control of Axon Development and Function by Ubiquitin

  2021cites this paper
• Genetic Influences in Breast Cancer Drug Resistance

  2021cites this paper
• Mitochondrial–nuclear p53 trafficking controls neuronal susceptibility in stroke

  2021cites this paper
• Tumor suppressor p53: Biology, signaling pathways, and therapeutic targeting.

  2021cites this paper
• Bimodal regulation of the PRC2 complex by USP7 underlies tumorigenesis

  2021cites this paper
• Functional Analysis of the Oncogene Carnitine Palmitoyltransferase 1C and Its Regulation under Hypoxia

  2021cites this paper
• Loss of peptidase D binding restores the tumor suppressor functions of oncogenic p53 mutants

  2021cites this paper
• Targeting SUMO Signaling to Wrestle Cancer.

  2020cites this paper
• Pathophysiology of Cancer Cell Death

  2020cites this paper
• TP53 alterations of hormone-naïve prostate cancer in the Chinese population

  2020cites this paper
• Chaperones and Ubiquitin Ligases Balance Mutant p53 Protein Stability in Esophageal and Other Digestive Cancers

  2020cites this paper
• Making Connections: p53 and the Cathepsin Proteases as Co-Regulators of Cancer and Apoptosis

  2020cites this paper